biostudies-literatureGhesquieres HJanssen-CilagAmgen SASRocheTakeda France SASCelgene International II SARL432https://www.ebi.ac.uk/biostudies/studies/S-EPMC7927409biostudies-literatureUnknown21(1)<h4>Background</h4>Age-adjusted lymphoma incidence rates continue to rise in France since the early 80's, although rates have slowed since 2010 and vary across subtypes. Recent improvements in patient survival in major lymphoma subtypes at population level raise new questions about patient outcomes (i.e. quality of life, long-term sequelae). Epidemiological studies have investigated factors related to lymphoma risk, but few have addressed the extent to which socioeconomic status, social institutional context (i.e. healthcare system), social relationships, environmental context (exposures), individual behaviours (lifestyle) or genetic determinants influence lymphoma outcomes, especially in the general population. Moreover, the knowledge of the disease behaviour mainly obtained from clinicalBMC public healthA French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.PMC7927409NAChartier LMonnereau ABernier AOberic LLe Guyader-Peyrou SBaldi ISujobert PLebras LDamaj GGuidez SRossi CFornecker LMMorschhauser FLe Gouill SYsebaert LGressin RSalles GHaioun CCherblanc FGhesquieres HBouabdallah KFitoussi OBelot ALaboure GLaurent CMorineau NBijou FFabbro-Peray PfalseA French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.<h4>Background</h4>Age-adjusted lymphoma incidence rates continue to rise in France since the early 80's, although rates have slowed since 2010 and vary across subtypes. Recent improvements in patient survival in major lymphoma subtypes at population level raise new questions about patient outcomes (i.e. quality of life, long-term sequelae). Epidemiological studies have investigated factors related to lymphoma risk, but few have addressed the extent to which socioeconomic status, social institutional context (i.e. healthcare system), social relationships, environmental context (exposures), individual behaviours (lifestyle) or genetic determinants influence lymphoma outcomes, especially in the general population. Moreover, the knowledge of the disease behaviour mainly obtained from clinical2021-01-01T00:00:00Z2021 Mar2026-05-02T12:10:56.151Z2021-03-06T08:12:38ZS-EPMC79274093365329410.1186/s12889-021-10433-4